Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomica e Trascrittomica Dei Gliomi a Basso ed Alto Grado (GlioMeTra) L2093

NCT07832734 is registered in ClinicalTrials.gov with I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio as lead sponsor.

NCT NCT07832734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07832734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomica e Trascrittomica Dei Gliomi a Basso ed Alto Grado (GlioMeTra) L2093
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2026
Completion date
March 31, 2029
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idh mutant lower-grade gliomas, idh wildtype glioblastoma